CHMP provides positive opinion for BMS’s Reblozyl
The positive opinion is based on findings from the Phase III COMMANDS trial which met its primary endpoint.
The positive opinion is based on findings from the Phase III COMMANDS trial which met its primary endpoint.
What's Your Reaction?
